Area riservata



Ipersensibilità allergica

Potential Key To New Treatment For Mantle Cell Lymphoma (MCL)
AllergologiaResearchers at Moffitt Cancer Center and colleagues have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable subtype of B-cell non-Hodgkin lymphoma that becomes resistant to treatment, can harness the immune system to eradicate residual malignant cells responsib...
Fonte: Immune System/Vaccines News From Medical News Today
 

Aggiungi commento


Codice di sicurezza
Aggiorna